Insider · CIK 0001735084
Nancy Miller-Rich
Files at ALDX (Aldeyra Therapeutics, Inc.), FDMT (4D Molecular Therapeutics, Inc.). First filing Oct 21, 2024, latest Oct 21, 2024.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ALDX: Aldeyra Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 17, 2025 | FDMT 4D Molecular Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +22,500 | $0.00 | $0 | 22,500 | Jun 20, 2025 |
| Jun 10, 2025 | ALDX Aldeyra Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +62,728 | $0.00 | $0 | 62,728 | Jun 12, 2025 |
| Jun 10, 2025 | ALDX Aldeyra Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +2,413 | $0.00 | $0 | 2,413 | Jun 12, 2025 |
| May 3, 2021 | ALDX Aldeyra Therapeutics, Inc. | POpen-market purchase Common Stock | +413 | $12.81 | $5,291 | 413 | Oct 21, 2024 |
| Apr 12, 2023 | ALDX Aldeyra Therapeutics, Inc. | POpen-market purchase Common Stock | +509 | $10.13 | $5,156 | 922 | Oct 21, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.